| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.31 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |